HK1156876A1 - Composition comprising an antibiotic and a corticosteroid - Google Patents

Composition comprising an antibiotic and a corticosteroid

Info

Publication number
HK1156876A1
HK1156876A1 HK11111313.4A HK11111313A HK1156876A1 HK 1156876 A1 HK1156876 A1 HK 1156876A1 HK 11111313 A HK11111313 A HK 11111313A HK 1156876 A1 HK1156876 A1 HK 1156876A1
Authority
HK
Hong Kong
Prior art keywords
corticosteroid
antibiotic
composition
Prior art date
Application number
HK11111313.4A
Other languages
English (en)
Inventor
Roger Tully
Keith Freehauf
Jay Brumfield
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of HK1156876A1 publication Critical patent/HK1156876A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK11111313.4A 2008-06-02 2011-10-20 Composition comprising an antibiotic and a corticosteroid HK1156876A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5794008P 2008-06-02 2008-06-02
PCT/EP2009/056751 WO2009147144A2 (en) 2008-06-02 2009-06-02 Composition comprising an antibiotic and a corticosteroid

Publications (1)

Publication Number Publication Date
HK1156876A1 true HK1156876A1 (en) 2012-06-22

Family

ID=41278754

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11111313.4A HK1156876A1 (en) 2008-06-02 2011-10-20 Composition comprising an antibiotic and a corticosteroid

Country Status (13)

Country Link
US (2) US20100087409A1 (pt)
EP (1) EP2293778B1 (pt)
JP (1) JP5674648B2 (pt)
CN (1) CN102083414B (pt)
AR (1) AR071988A1 (pt)
AU (1) AU2009253956B2 (pt)
BR (1) BRPI0913297B8 (pt)
CA (1) CA2726074C (pt)
ES (1) ES2436193T3 (pt)
HK (1) HK1156876A1 (pt)
RU (1) RU2496501C2 (pt)
TW (1) TW201010708A (pt)
WO (1) WO2009147144A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1776109T3 (da) 2004-08-13 2009-05-04 Schering Plough Ltd Farmaceutisk formulering omfattende et antibiotikum, en triazol og et cortocosteroid
JP2013545800A (ja) 2010-12-20 2013-12-26 コルゲート・パーモリブ・カンパニー 親水性活性剤、疎水性構造化剤および油担体を含有するゼラチンカプセル化された口腔ケア組成物
EP2502616A1 (fr) * 2011-03-21 2012-09-26 Matthew Krayenbuhl Composition pharmaceutique nasale
AU2013208252B2 (en) * 2012-01-10 2016-03-03 Entrx LLC Otic formulations, methods and devices
US9849126B2 (en) 2013-01-03 2017-12-26 Entrx LLC Sterile otic formulations
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
CN109689034A (zh) * 2016-06-13 2019-04-26 维奥梅治疗有限公司 协同抗真菌组合物及其方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6013711A (ja) * 1983-06-21 1985-01-24 ザ、プロクタ−、エンド、ギヤンブル、カンパニ− コルチコステロイドを含有する浸透局所製薬組成物
EP0587790B2 (en) * 1991-06-10 2000-03-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5710886A (en) * 1995-06-16 1998-01-20 Sellectsoft, L.C. Electric couponing method and apparatus
US7917386B2 (en) * 1995-06-16 2011-03-29 Catalina Marketing Corporation Virtual couponing method and apparatus for use with consumer kiosk
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
EP1179002A4 (en) * 1999-05-07 2002-08-07 Smithkline Beecham Corp METHODS USING MECHANISMS OF ACTION OF AROA
US20080052169A1 (en) * 2000-03-29 2008-02-28 O'shea Deirdre Method and apparatus for providing a coupon offer having a variable value
RU2201219C2 (ru) * 2001-04-24 2003-03-27 Макаров Константин Алексеевич Фармакологическая композиция пролонгированного действия
US6589955B2 (en) * 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
WO2003025822A1 (en) * 2001-09-19 2003-03-27 Matsushita Electric Corporation Of America Adaptive electronic coupon
RU2267491C1 (ru) * 2004-07-14 2006-01-10 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Физиологически активная композиция, замещенные 1-оксо-1,2-дигидро[2,7]-нафтиридины, способ их получения, применения и набор
ES2331313T3 (es) * 2003-11-07 2009-12-29 Senju Pharmaceutical Co., Ltd. Composicion farmaceutica que contiene prostaglandina.
US20050118206A1 (en) * 2003-11-14 2005-06-02 Luk Andrew S. Surfactant-based gel as an injectable, sustained drug delivery vehicle
DK1776109T3 (da) * 2004-08-13 2009-05-04 Schering Plough Ltd Farmaceutisk formulering omfattende et antibiotikum, en triazol og et cortocosteroid
US20060041469A1 (en) * 2004-08-18 2006-02-23 Torrance Mathis Marketing system employing electronically generated discount coupons
US20120121653A1 (en) * 2005-12-02 2012-05-17 Elan Pharma International Limited Novel mometasone compositions and methods of making and using the same
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
EP2278957A2 (en) * 2008-04-15 2011-02-02 Schering Corporation Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas

Also Published As

Publication number Publication date
US10045940B2 (en) 2018-08-14
TW201010708A (en) 2010-03-16
RU2496501C2 (ru) 2013-10-27
EP2293778A2 (en) 2011-03-16
CN102083414B (zh) 2013-10-23
JP5674648B2 (ja) 2015-02-25
CN102083414A (zh) 2011-06-01
US20120046259A1 (en) 2012-02-23
CA2726074C (en) 2016-07-19
BRPI0913297A2 (pt) 2016-01-26
US20100087409A1 (en) 2010-04-08
WO2009147144A3 (en) 2010-09-16
ES2436193T3 (es) 2013-12-27
BRPI0913297B1 (pt) 2019-01-29
AU2009253956B2 (en) 2016-05-12
CA2726074A1 (en) 2009-12-10
EP2293778B1 (en) 2013-09-18
WO2009147144A2 (en) 2009-12-10
RU2010154083A (ru) 2012-07-20
BRPI0913297B8 (pt) 2020-09-15
JP2011521999A (ja) 2011-07-28
AU2009253956A1 (en) 2009-12-10
AR071988A1 (es) 2010-07-28

Similar Documents

Publication Publication Date Title
IL276342A (en) A pharmaceutical composition that includes an antibiotic and a suspending agent or an anti-caking agent
IL284824A (en) Corticosteroid preparations
EP2419670B8 (en) Delivery method and compositions
ZA201003696B (en) Compositions and devices
GB0709781D0 (en) Composition and method
GB0821928D0 (en) Antibiotic nanomaterial
HK1156876A1 (en) Composition comprising an antibiotic and a corticosteroid
GB0724967D0 (en) Composition and method
TWI367763B (en) Compositions and devices
IL196883A0 (en) Antibiotic composition
GB0918601D0 (en) Decahydro-1H-Indenoquinolinone and decahydro-3H-cyclopenaphenanthridinone CYP17 inhibitors
WO2011060427A9 (en) Composition and methods for affecting cytokines and nf-kb
ZA201008680B (en) Fulvic acid and antibiotic combination
ZA201103961B (en) A composition and a method thereof
AU2014200650C1 (en) Anti-CXCR1 compositions and methods
AU2008903953A0 (en) Methods and compositions
AU2008904402A0 (en) Methods and compositions
AU2009902446A0 (en) Loading structure and components
AU2008903893A0 (en) Up and outz
AU2008901168A0 (en) Up and outz
AU2008904407A0 (en) Serve and Save
AU2007905574A0 (en) Composition and Method
AU2007905573A0 (en) Composition and Method
AU2007905486A0 (en) Composition and method
AU2007905485A0 (en) Composition and method